Literature DB >> 18571550

Pattern and course of neurodegeneration in Langerhans cell histiocytosis.

Martha Wnorowski1, Helmut Prosch, Daniela Prayer, Gisela Janssen, Helmut Gadner, Nicole Grois.   

Abstract

OBJECTIVE: To explore the frequency and course of neurodegenerative central nervous system (CNS) disease in Langerhans cell histiocytosis (ND-LCH). STUDY
DESIGN: We studied 83 patients with LCH in whom magnetic resonance imaging (MRI) of the brain was performed at least twice for various clinical indications. We defined radiologic ND-LCH as an MRI pattern comprising bilateral symmetric lesions in the dentate nucleus of the cerebellum or basal ganglia.
RESULTS: Forty-seven of 83 patients (57%) had radiologic ND-LCH, at a median of 34 months (range 0-16 years) from the diagnosis of LCH. The MRI findings deteriorated in 31/47 (66%) patients over a median of 3 years (range 2 months to 12 years 6 months) and did not reverse in any patient. In 12 patients with radiologic ND-LCH (25%), clinical ND-LCH with overt symptoms were found 3 to 15 years (median 6 years) after initial LCH diagnosis. These symptoms included intention tremor, cerebellar ataxia, dysarthria, dysdiadochokinesis, concentration deficits, psychomotor retardation, severe headaches, and psychosis.
CONCLUSION: We conclude that radiologic ND-LCH is serious, not uncommon in patients studied by MRI, irreversible, and may be followed by severe clinical ND-LCH many years after the initial diagnosis of LCH.

Entities:  

Mesh:

Year:  2008        PMID: 18571550     DOI: 10.1016/j.jpeds.2007.12.042

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  19 in total

1.  Analysis of 43 cases of Langerhans cell histiocytosis (LCH)-induced central diabetes insipidus registered in the JLSG-96 and JLSG-02 studies in Japan.

Authors:  Yoko Shioda; Souichi Adachi; Shinsaku Imashuku; Kazuko Kudo; Toshihiko Imamura; Akira Morimoto
Journal:  Int J Hematol       Date:  2011-11-17       Impact factor: 2.490

Review 2.  Acquired hepatocerebral degeneration.

Authors:  Joseph Ferrara; Joseph Jankovic
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

Review 3.  Neuroimaging of Langerhans cell histiocytosis: a radiological review.

Authors:  Vikas Chaudhary; Shahina Bano; Rainy Aggarwal; Mahender Kaur Narula; Rama Anand; Ravi Shankar Solanki; Puran Singh
Journal:  Jpn J Radiol       Date:  2013-12       Impact factor: 2.374

4.  How I treat Langerhans cell histiocytosis.

Authors:  Carl E Allen; Stephan Ladisch; Kenneth L McClain
Journal:  Blood       Date:  2015-03-31       Impact factor: 22.113

5.  Langerhans Cell Histiocytosis Presenting With Late-Onset Sporadic Ataxia.

Authors:  Inder Puri; Divyani Garg; Achal Kumar Srivastava; Lavleen Singh; Garima Shukla; Vinay Goyal
Journal:  Mov Disord Clin Pract       Date:  2019-09-18

Review 6.  Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.

Authors:  Milen Minkov
Journal:  Paediatr Drugs       Date:  2011-04-01       Impact factor: 3.022

7.  A patient with diabetes insipidus, anterior hypopituitarism and pituitary stalk thickening.

Authors:  Nicholas A Tritos; Thomas N Byrne; Chin-Lee Wu; Anne Klibanski
Journal:  Nat Rev Endocrinol       Date:  2010-11-23       Impact factor: 43.330

8.  Follow-up of pediatric patients treated by IVIG for Langerhans cell histiocytosis (LCH)-related neurodegenerative CNS disease.

Authors:  Shinsaku Imashuku; Naoto Fujita; Yoko Shioda; Haruyoshi Noma; Shiro Seto; Toshinori Minato; Kazuo Sakashita; Nobuhiro Ito; Ryoji Kobayashi; Akira Morimoto
Journal:  Int J Hematol       Date:  2014-12-10       Impact factor: 2.490

9.  Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside.

Authors:  Carl E Allen; Ricardo Flores; Ronald Rauch; Robert Dauser; Jeffrey C Murray; Diane Puccetti; David A Hsu; Paul Sondel; Maxine Hetherington; Stan Goldman; Kenneth L McClain
Journal:  Pediatr Blood Cancer       Date:  2010-03       Impact factor: 3.167

10.  Dentate nucleus T1 hyperintensity: is it always gadolinium all that glitters?

Authors:  Luca Pasquini; Maria Camilla Rossi Espagnet; Antonio Napolitano; Daniela Longo; Alice Bertaina; Emiliano Visconti; Paolo Tomà
Journal:  Radiol Med       Date:  2018-01-27       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.